Pulmonary Arterial Hypertension  >>  emiplacel (PLX-PAD)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emiplacel (PLX-PAD) / Pluri, Charite - University of Medicine Berlin
NCT01795950: Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

Terminated
1
6
RoW
PLX-PAD, allogeneic Mesenchymal-like Adherent Stromal Cells (ASCs)
United Therapeutics
Pulmonary Arterial Hypertension
12/15
01/16

Download Options